Day Two - EST/EDT (Eastern Daylight, GMT-4)
Day Two - EST/EDT (Eastern Daylight, GMT-4)
- Paul Chen - Senior Director, Trade and Channel Management, Lexicon Pharmaceuticals
An exploration of Hub case studies during launch and migration
Process and stakeholder optimization
Maximizing data and reporting
Appropriate blend of AI and human touch
- Chris Dowd - Senior Vice President, ConnectiveRx
- Sam Blake - Vice President, Launch Excellence, Implementation Management, ConnectiveRx
Gain insight into current policies and upcoming future changes
Discuss how to handle Medicaid disenrollment’s, including patient education and the newfound burden on patient assistance programs
Check in on the current status of the Infflation Reduction Act, it’s already visible consequences and how manufacturers can still provide the necessary commercial support
- Jennie Sakimura - Senior Director, Patient Support Services, Sanofi
- Mallory O’Connor - Executive Director, Public Policy, Mallinckrodt
Provide a comprehensive understanding of the existing regulatory landscape governing patient support services and hub models, including FDA guidelines, compliance standards, and industry best practices
Gain valuable insights into the latest enforcement actions and the ramifications of recent cases
Uncover the top areas of focus for 2024
- Joel White - President, Horizon Government Affairs
- Jason Gould - Chief, Health Care Fraud Unit, United States Attorney's Office, District of New Jersey
- Matt Howatt - Assistant US Attorney, U.S. Attorney’s Office for the Eastern District of Pennsylvania
- Steven Sharobem - Assistant United States Attorney, US Attorney’s Office, District of Massachusetts
- Understand the opportunity to digitize and automate the patient experience within hubs
- Compare digital solutions for small vs large patient populations
- Learn how to connect to a fractured EHR and workflow solution market
- Gain insights into the future of patient affordability and how to reach more patients with financial solutions
- Discuss best practices on how to maximize the value of digital automation
- Tom Doyle - SVP of Sales, Chief Customer Officer for BioPharma Services, Cencora
- Myra Reinhardt - Vice President of Customer Solutions, Cencora
- Gemi Bryant - Director of Customer Solutions, Cencora
- Cindy Baksh - Vice President of Access & Affordability, Cencora
Explore the existing landscape regarding manufacturers’ and pharmacy providers’ roles in the prior authorization (PA) process
Assess legislative and standard updates in the specialty market
Discuss best practices in compliantly expediting the PA process
Examine different ways to decrease time to fill and optimize HCP workflow
Hear updates on solution capabilities and accuracy for electronic benefit verification
Assess how this affects the hub and the role of the physician
Dive into benefit design and network management by unpacking strategies for specialty pharmacy benefits and specialty medical benefits
- Melissa Beatty - Executive Director, Patient Services, Zevra Therapeutics
- Kevin O'Meara - Vice President, Patient Services, EVERSANA
- Joel White - President, Horizon Government Affairs
Understand the benefit of cross functional collaboration when working with key partners (ie. vendors)
Discuss the importance of being proactive vs reactive when working with legal and compliance and
Define the commercial team’s role within patient services
Benchmark with colleagues on the best practices that can be instated in the respective departments to create and foster a relationship that is collaborative, mutualistic and working toward the common goal of helping the patient
- Stuart Kamin - Senior Vice President, Corporate Strategy and Business Development, ClaritasRx
- Meghan Szczech, MBA - Executive Director, Patient Services and Trade, SK Life Science Inc
- Thomas Luby - Senior Vice President, Business Development, Phil Inc.
- Catherine Wood Hill - Vice President, Marketing, Phil Inc.
During this session, take a deep dive into the best practices of both evaluating and managing your Hub partner. Understand how to look at different Hubs to determine which is the best fit for your company to ensure a blend of cultures and a seamless transition. Learn how to manage the partnership as an extension of your organization, emphasizing the importance of constant internal benchmarking and subsequent re-strategization to ensure continued model success.
- Paul Chen - Senior Director, Trade and Channel Management, Lexicon Pharmaceuticals
- Scott Murray - Senior Director, Payer Marketing and Strategy, Lexicon Pharmaceuticals
Due to a lack of explicit government guidance, manufacturers must be highly aware of investigation, enforcement activity, Anti-Kickback and more within their Hub activity. Identify the steps to take, and the due diligence that must be had, surrounding Hub development and execution in order to mitigate risk.
- Omar Richardson - Senior Director of Compliance, Shionogi Inc.
- Shannon Moesaa - Vice President, Commercial and Healthcare Compliance Counsel, Karuna Therapeutics
- Join fellow industry leaders to identify 2024’s biggest market challenges
- Collaborate and learn from each other’s successes to uncover new solutions
- Gain actionable takeaways from your peers to power your patient support programs and support the patient access journey
- Brok Vandersteen - Vice President, Business Development, AssistRx
- Jan Nielsen - Division President, Patient Solutions, AssistRx
- Stacey Little - Senior Vice President, Business Development and Marketing, AssistRx
- Michael Carr - Group Vice President, CoAssist Pharmacy, AssistRx
- Jordan Armstrong - VP, Business Development, AssistRx
- Irene Sheynis-Vega - Senior Manager, Patient Access and Reimbursement, Amgen
- Jennie Sakimura - Senior Director, Patient Support Services, Sanofi
- Paul Hunter - Vice President, Market Access and Commercial Operations, Halozyme
- DeWayne Manning - Partner, Archbow Consulting
- Andrea Burgess - Director, New Product Planning, Takeda